Vanessa Preumont

Efficacy and safety of oral semaglutide with flexible dose adjustment versus sitagliptin in type 2 diabetes (PIONEER 7): a multicentre, open-label, randomised, phase 3a trial

Thomas R. Pieber, Bruce W. Bode, Young Min Cho et al. · The Lancet Diabetes & Endocrinology · 2019 · 274 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +9

Comparing advanced hybrid closed loop therapy and standard insulin therapy in pregnant women with type 1 diabetes (CRISTAL): a parallel-group, open-label, randomised controlled trial

Katrien Benhalima, Kaat Beunen, Nancy Van Wilder et al. · The Lancet Diabetes & Endocrinology · 2024 · 110 citations · Full text

Medicine, Endocrinology, Obstetrics +15

Improvement of psoriasis during glucagon-like peptide-1 analogue therapy in type 2 diabetes is associated with decreasing dermal γδ T-cell number: a prospective case-series study

Martin Buysschaert, Marie Baeck, Vanessa Preumont et al. · British Journal of Dermatology · 2014 · 99 citations

Medicine, Dermatology, Immunology +17

One-year metabolic outcomes in patients with type 2 diabetes treated with exenatide in routine practice

Martin Buysschaert, Vanessa Preumont, Philippe Oriot et al. · Diabetes & Metabolism · 2010 · 70 citations

Medicine, Endocrinology, Internal Medicine +12

Improvement of psoriasis during exenatide treatment in a patient with diabetes

Martin Buysschaert, Dominique Tennstedt, Vanessa Preumont · Diabetes & Metabolism · 2012 · 51 citations

Medicine, Internal Medicine, Pharmacotherapy +10